Stay updated on MGD013 and Brivanib in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the MGD013 and Brivanib in Liver Cancer Clinical Trial page.

Latest updates to the MGD013 and Brivanib in Liver Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page history shows a new revision entry (v3.4.2) replacing the previous revision (v3.4.1). This update is limited to release notes and does not alter study data or visible content on the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedAdded a new revision entry v3.4.1 and removed v3.4.0 from the history, reflecting a minor update to the page's version history.SummaryDifference0.1%

- Check19 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0 from the record history.SummaryDifference0.1%

- Check27 days agoChange DetectedUI enhancements include a glossary toggle, color-coded highlights for additions (green) and deletions (red), and an updated footer showing Revision: v3.4.0; the 'No FEAR Act Data' entry was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check41 days agoChange DetectedThe page history shows a new entry: Revision: v3.3.4 replacing v3.3.3. There are no visible changes to study data or critical information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter updates include adding 'Revision: v3.3.3' and removing 'HHS Vulnerability Disclosure' in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to MGD013 and Brivanib in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MGD013 and Brivanib in Liver Cancer Clinical Trial page.